Linda Pullan is an experienced business development consultant and board member with a diverse background in the biotech and pharmaceutical industries. Currently serving as a Member of The Supervisory Board at NLC Health Ventures, Linda has also founded Pullan Consulting, providing expertise to biotech, pharma, and academic organizations since 2006. Prior roles include VP of Business Development at Kosan Biosciences, where responsibilities encompassed managing all business development activities, and Director of Licensing at Amgen, focusing on in-licensing potential drugs and technologies. Linda's earlier career includes significant positions in technology licensing at Zeneca Pharmaceuticals and AstraZeneca, as well as leading drug discovery research at Monsanto Searle. Linda holds a Ph.D. in Biochemistry from the University of California, Riverside, and a B.S. in Chemistry with a Biology minor from the University of Utah.